Position in AZN
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$519,677,460
New position
Shares Held
2,635,014
first reported quarter
Ownership
0.170%
of shares outstanding
% of Portfolio
0.42%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 97.02502416496617.ToString("F0")%
Shared 0.ToString("F0")%
None 2.9749758350338307.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026NEUBERGER BERMAN GROUP LLC holds $4,420,797,879 across 15 Drug Manufacturers - General names. AZN ranks #3 (11.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,732,649 | $1,593,638,569 | |
| 2 | JNJ |
Johnson & Johnson
|
3,642,540 | $890,382,477 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
2,635,014 | $519,677,460 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,280,851 | $394,653,566 | |
| 5 | PFE |
Pfizer Inc
|
9,693,119 | $272,182,780 | |
| 6 | ABBV |
AbbVie Inc.
|
1,234,836 | $268,564,481 | |
| 7 | AMGN |
Amgen Inc
|
585,971 | $206,173,895 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,331,058 | $185,509,553 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $519,677,460 | 2,635,014 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||